04/28/2025
3:15 PM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form DEFA14A | |
04/02/2025
11:15 PM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form EFFECT | |
04/02/2025
11:15 PM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form EFFECT | |
04/02/2025
11:15 PM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form EFFECT | |
04/02/2025
11:15 PM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form EFFECT | |
04/01/2025
5:39 AM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form POS AM | |
04/01/2025
5:39 AM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form POS AM | |
04/01/2025
5:42 AM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form POS AM | |
04/01/2025
5:42 AM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form POS AM | |
03/10/2025
7:30 AM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/10/2025
7:30 AM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for FBIO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Fortress Biotech and its competitors with MarketBeat's FREE daily newsletter. |
02/27/2025
3:25 PM | Checkpoint Therapeutics, Inc. (Issuer)
Fortress Biotech (Reporting)
Fortress Biotech, Inc. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
3:20 PM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/06/2025
7:05 AM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2025
5:26 PM | Checkpoint Therapeutics, Inc. (Subject)
Fortress Biotech (Filed by)
Fortress Biotech, Inc. (Filed by)
| Form SCHEDULE 13D/A | |
01/03/2025
5:26 PM | Fortress Biotech (Filed by)
Fortress Biotech, Inc. (Filed by)
MUSTANG BIO, INC. (Subject)
| Form SCHEDULE 13D/A | |
01/03/2025
4:50 PM | AVENUE THERAPEUTICS, INC. (Subject)
Fortress Biotech (Filed by)
Fortress Biotech, Inc. (Filed by)
| Form SCHEDULE 13D/A | |
01/03/2025
3:20 PM | Fortress Biotech (Reporting)
Fortress Biotech, Inc. (Reporting)
MUSTANG BIO, INC. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/03/2025
3:21 PM | AVENUE THERAPEUTICS, INC. (Issuer)
Fortress Biotech (Reporting)
Fortress Biotech, Inc. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/23/2024
3:30 PM | Fortress Biotech (Issuer)
Fortress Biotech, Inc. (Issuer)
Jin David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:50 PM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:24 PM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
8:11 AM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
3:05 PM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form 424B3 | |
10/25/2024
9:15 AM | Fortress Biotech (Subject)
Fortress Biotech, Inc. (Subject)
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G | |
10/07/2024
11:15 PM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form EFFECT | |
09/27/2024
3:53 PM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
09/25/2024
3:45 PM | Fortress Biotech (Issuer)
Fortress Biotech, Inc. (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2024
3:45 PM | Fortress Biotech (Subject)
Fortress Biotech, Inc. (Subject)
ROSENWALD LINDSAY A MD (Filed by)
| Form SC 13D/A | |
09/23/2024
7:00 AM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form 424B5 | |
09/20/2024
8:28 AM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form 424B5 | |
08/13/2024
3:15 PM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2024
4:04 PM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form 424B5 | |
07/25/2024
4:26 PM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
7:00 AM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2024
7:42 AM | Fortress Biotech (Issuer)
Fortress Biotech, Inc. (Issuer)
Jin David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
7:00 AM | Fortress Biotech (Issuer)
Fortress Biotech, Inc. (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
7:30 AM | Fortress Biotech (Issuer)
Fortress Biotech, Inc. (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2024
3:46 PM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2024
7:40 AM | Fortress Biotech (Issuer)
Fortress Biotech, Inc. (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
3:33 PM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Musk’s Project Colossus could mint millionaires (Ad) I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history.
And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. All the details are waiting for you now — but you need to act before the May 1st funding window clos |
06/28/2024
3:22 PM | Fortress Biotech (Reporting)
Fortress Biotech, Inc. (Reporting)
MUSTANG BIO, INC. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
3:26 PM | Fortress Biotech (Filed by)
Fortress Biotech, Inc. (Filed by)
MUSTANG BIO, INC. (Subject)
| Form SC 13D/A | |
06/27/2024
11:15 PM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form EFFECT | |
06/27/2024
3:25 PM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form 424B3 | |
05/31/2024
5:25 PM | Fortress Biotech (Reporting)
Fortress Biotech, Inc. (Reporting)
Journey Medical Corp (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/31/2024
5:26 PM | Fortress Biotech (Reporting)
Fortress Biotech, Inc. (Reporting)
Journey Medical Corp (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
11:15 PM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form EFFECT | |
05/29/2024
4:04 PM | Fortress Biotech (Filer)
Fortress Biotech, Inc. (Filer)
| Form S-3/A | |
05/24/2024
3:05 PM | Checkpoint Therapeutics, Inc. (Issuer)
Fortress Biotech (Reporting)
Fortress Biotech, Inc. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
